StocksDeepDive
Snapshot · SMI · generated 2026-10-15 20:44 UTC

NOVN.SW — Novartis AG

UNDERVALUED (MOS +35.9%) · Quality 65/100

Price
125.9
Intrinsic value
196.45
Margin of safety
+35.9%
Implied growth (reverse DCF)
+0.9%
model assumes +8.0%
Value Score
41.4
Quality
65
Psychology
-10.4
Discovery
58.6
price/volume attention only
Moat score
70.5
erosion: none

Value Score: bottom 48% of SMI · Quality: top 42%

Dividend: 3.7/share (TTM) · yield 2.9% · payout 69%

Open the interactive Deep Dive for NOVN.SW →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NOVN.SW - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NOVN.SW undervalued?

As of 2026-10-15, NOVN.SW trades at 125.9 against a computed intrinsic value of 196.45 (+35.9% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Novartis AG's Value Score?

Novartis AG's Value Score is 41.4 as of 2026-10-15 - it combines value, quality, crowd psychology and market attention into one number.

Does NOVN.SW pay a dividend?

Yes - NOVN.SW's trailing twelve-month dividend is 3.7/share, a yield of 2.9% at the current price (as of 2026-10-15).